Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Imipenem resistance in Pseudomonas aeruginosa: emergence, epidemiology, and impact on clinical and economic outcomes.

Lautenbach E, Synnestvedt M, Weiner MG, Bilker WB, Vo L, Schein J, Kim M.

Infect Control Hosp Epidemiol. 2010 Jan;31(1):47-53. doi: 10.1086/649021.

PMID:
19951202
2.

Mortality attributable to carbapenem-resistant Pseudomonas aeruginosa bacteremia: a meta-analysis of cohort studies.

Zhang Y, Chen XL, Huang AW, Liu SL, Liu WJ, Zhang N, Lu XZ.

Emerg Microbes Infect. 2016 Mar 23;5:e27. doi: 10.1038/emi.2016.22. Review.

3.

Prevalence and risk factors associated with colonization and infection of extensively drug-resistant Pseudomonas aeruginosa: a systematic review.

Buhl M, Peter S, Willmann M.

Expert Rev Anti Infect Ther. 2015;13(9):1159-70. doi: 10.1586/14787210.2015.1064310. Epub 2015 Jul 7. Review.

PMID:
26153817
4.

A systematic review and meta-analyses show that carbapenem use and medical devices are the leading risk factors for carbapenem-resistant Pseudomonas aeruginosa.

Voor In 't Holt AF, Severin JA, Lesaffre EM, Vos MC.

Antimicrob Agents Chemother. 2014 May;58(5):2626-37. doi: 10.1128/AAC.01758-13. Epub 2014 Feb 18. Review.

5.

A Comprehensive Analysis of the Impact of Pseudomonas aeruginosa Colonization on Prognosis in Adult Bronchiectasis.

Finch S, McDonnell MJ, Abo-Leyah H, Aliberti S, Chalmers JD.

Ann Am Thorac Soc. 2015 Nov;12(11):1602-11. doi: 10.1513/AnnalsATS.201506-333OC. Review.

PMID:
26356317
6.

Impact of multidrug-resistant Pseudomonas aeruginosa infection on patient outcomes.

Hirsch EB, Tam VH.

Expert Rev Pharmacoecon Outcomes Res. 2010 Aug;10(4):441-51. doi: 10.1586/erp.10.49. Review.

7.

Prevalence of Pseudomonas aeruginosa and antimicrobial-resistant Pseudomonas aeruginosa in patients with pneumonia in mainland China: a systematic review and meta-analysis.

Ding C, Yang Z, Wang J, Liu X, Cao Y, Pan Y, Han L, Zhan S.

Int J Infect Dis. 2016 Aug;49:119-28. doi: 10.1016/j.ijid.2016.06.014. Epub 2016 Jun 18. Review.

8.

Pseudomonas skin infection: clinical features, epidemiology, and management.

Wu DC, Chan WW, Metelitsa AI, Fiorillo L, Lin AN.

Am J Clin Dermatol. 2011 Jun 1;12(3):157-69. doi: 10.2165/11539770-000000000-00000. Review.

PMID:
21469761
9.

Epidemiology of VIM-1-imipenem resistant Pseudomonas aeruginosa in Iran: A systematic review and meta-analysis.

Sedighi M, Salehi-Abargouei A, Oryan G, Faghri J.

J Res Med Sci. 2014 Sep;19(9):899-903. Review.

Supplemental Content

Support Center